Go Pro
→ How Long Does $2.5M Last in Retirement? (From SmartAsset) (Ad)tc pixel Free CMMB Stock Alerts

Chemomab Therapeutics (CMMB) Stock Chart & Stock Price History

Chemomab Therapeutics logo
$2.83 +0.10 (+3.66%)
As of 09/3/2026 04:00 PM Eastern
Compare

Chemomab Therapeutics Stock Price Performance

The Chemomab Therapeutics (CMMB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 7.21%, with a year-to-date return of 71.52%. In the past month, the stock has increased 68.45%, reflecting recent market activity.

As of the latest close, Chemomab Therapeutics traded at $2.83 with a market cap of $20.52 million and volume of 150,841 shares. Five years ago, the stock traded at a split-adjusted price of $58.60, representing a 95.17% decrease over that period. At the time, it had a market cap of $166.98 million and a volume of 7,607 shares.

Receive CMMB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
+4.43%
1 Month
Performance
+68.45%
3 Month
Performance
+57.22%
Year-To-Date
Performance
+71.52%
1 Year
Performance
-7.21%
5 Year
Performance
-95.17%

CMMB Stock Chart for Friday, September, 4, 2026

CMMB Chart by TradingView

Chemomab Therapeutics Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/03/2026$2.73$2.83
+3.66%		$2.94$2.71150,841 shs$20.52 million
09/02/2026$2.73$2.73$2.84$2.7141,307 shs$19.79 million
09/01/2026$2.72$2.73
+0.37%		$2.89$2.7072,385 shs$19.79 million
08/31/2026$2.71$2.72
+0.37%		$2.80$2.6441,595 shs$19.72 million
08/28/2026$2.72$2.71
-0.37%		$2.88$2.61105,037 shs$19.51 million
08/27/2026$2.59$2.72
+5.02%		$2.99$2.57379,597 shs$18.65 million
08/26/2026$2.30$2.59
+12.61%		$2.65$2.32420,460 shs$18.65 million
08/25/2026$2.17$2.30
+5.99%		$2.37$2.12139,567 shs$16.56 million
08/24/2026$2.16$2.17
+0.46%		$2.27$2.0879,734 shs$15.62 million
08/21/2026$2.07$2.16
+4.35%		$2.20$2.04114,191 shs$15.55 million
08/20/2026$2.09$2.07
-0.96%		$2.10$1.9581,059 shs$14.90 million
08/19/2026$1.91$2.09
+9.42%		$2.11$1.88118,763 shs$15.05 million
08/18/2026$1.92$1.91
-0.52%		$1.92$1.8717,215 shs$13.75 million
08/17/2026$1.91$1.92
+0.52%		$2.00$1.9042,274 shs$13.82 million
08/14/2026$1.90$1.91
+0.53%		$1.92$1.8421,557 shs$13.75 million
08/13/2026$1.92$1.90
-1.04%		$1.94$1.8916,075 shs$13.68 million
08/12/2026$1.90$1.92
+1.05%		$2.04$1.8733,461 shs$13.82 million
08/11/2026$1.89$1.90
+0.53%		$1.92$1.8618,122 shs$13.68 million
08/10/2026$1.93$1.89
-2.07%		$1.98$1.8133,422 shs$13.61 million
08/07/2026$1.80$1.93
+7.22%		$2.04$1.83137,594 shs$13.90 million
08/06/2026$1.75$1.80
+2.86%		$1.86$1.76119,008 shs$12.96 million
08/05/2026$1.68$1.75
+4.17%		$1.80$1.6897,763 shs$12.60 million
08/04/2026$1.62$1.68
+3.70%		$1.68$1.6038,587 shs$12.10 million
08/03/2026$1.55$1.62
+4.52%		$1.63$1.5377,299 shs$11.66 million
Related Companies

This page (NASDAQ:CMMB) was last updated on 9/3/2026 by MarketBeat.com Staff.
From Our Partners
How Long Does $2.5M Last in Retirement?
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
Before Anthropic becomes impossible to ignore...
Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
In 1984, a 10000 dollar stake in Apple could have grown to 25 million dollars for early investors who simply g...
Eagle Publishing | Sponsoredtc pixel